跳至主要内容
临床试验/ISRCTN41687085
ISRCTN41687085已完成未知

A randomised, open label controlled trial of Epoetin Beta in the treatment of Anaemia Post-Transplantation

Barts and the London NHS Trust (UK)0 个研究点目标入组 120 人开始时间: 2006年10月3日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male and female patients greater than three months post-kidney transplant
  • 2. Haemoglobin less than 11.5 g/dl and greater than 9.0 g/dl
  • 3. Age greater than 18 years of age and less than 85 years of age

排除标准

  • 1. Current treatment with an erythropoiesis stimulating agent (ESA)
  • 2. Uncontrolled hypertension
  • 3. Congestive cardiac failure (New York Heart Association [NYHA] grade III and IV)
  • 4. History of seizures
  • 5. History of thombotic episodes
  • 6. Pregnancy
  • 7. Lactation
  • 8. Presence of systemic disease, infection or inflammatory conditions
  • 9. Hepatic insufficiency
  • 10. Active hepatitis
  • 11. Uncontrolled hypothyroidism
  • 12. Chronic alcoholism
  • 13. Known hypersensitivity to the active substance in the cartridge or benzoic acid
  • 14. Known sensitivity to Epoetin Beta

研究者

发起方
Barts and the London NHS Trust (UK)

相似试验

A randomised, open label controlled trial of Epoetin... | 临床试验